Consistent with these results, we further demonstrated that the T variant of LGALS3 rs2274273 genotypes, the A variant of LGALS3 rs4644 genotypes and the C variant of LGALS3 4,652 genotypes were associated with relatively low galectin‐3 levels in patients with CAD, and the effect size was similar to that evident in the general population, as reported by Boer et al. (de Boer, Verweij, et al., 2012). The gene discussed is LGALS3; the disease is coronary artery disorder.